Arbutus Biopharma Corporation ABUS Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's accumulated depreciation?
- Arbutus Biopharma Corporation (ABUS) reported accumulated depreciation of $224K in Q1 2026.
- How has Arbutus Biopharma Corporation's accumulated depreciation changed year-over-year?
- Arbutus Biopharma Corporation's accumulated depreciation decreased by 98.3% year-over-year, from $13.33M to $224K.
- What is the long-term trend for Arbutus Biopharma Corporation's accumulated depreciation?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's accumulated depreciation has grown at a -51.1% compound annual growth rate (CAGR), from $7.62M to $213K.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.